Navigation Links
Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102
Date:2/26/2013

TOKYO, Feb. 27, 2013 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. announced on February 27 that it submitted an application on February 26 for approval of the manufacture and marketing of the novel oral nucleoside antitumor agent TAS-102 (combination of trifluorothymidine (FTD) and tipiracil hydrochloride (TPI) ) to the Japanese Ministry of Health, Labor and Welfare. Taiho Pharmaceutical is seeking approval of TAS-102 for the indication of unresectable, advanced, recurrent colorectal cancer.

The application for approval is based on the results of a Phase II clinical trial (Study 10040030) conducted at 20 facilities throughout Japan. It was a randomized, double-blind comparative study of TAS-102 and a placebo involving 172 patients with unresectable, advanced, recurrent colorectal cancer that was refractory to the standard chemotherapy of at least two or more regimens containing fluoropyrimidine, irinotecan, and oxaliplatin. The results indicated that the group administered TAS-102 had improved overall survival rates (median overall survival: 9.0 months vs. 6.6 months) and a significantly reduced risk of mortality (HR: 0.56, p=0.0011). The most frequently reported adverse drug reaction with a CTCAE grade of 3 or higher was neutropenia. Grade 3 or higher diarrhea, fatigue, nausea, and other adverse reactions were no more than 10%. Taiho Pharmaceutical is currently proceeding with a global Phase III clinical trial of TAS-102 in a similar colorectal cancer population (RECOURSE) with the ultimate goal of global registration and commercialization of the agent.

Taiho Pharmaceutical believes that TAS-102 will make a significant contribution to cancer patients and will continue its development efforts to broaden its use.

About TAS-102
TAS-102 is an antitumor agent composed of a combination of trifluorothymidine (FTD), a nucleoside that incorporates into DNA and inhibits a variety of gene
'/>"/>

SOURCE Taiho Pharmaceutical Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Taiho Pharmaceutical présente une demande dhomologation pour la fabrication et la commercialisation du nouvel agent antitumoral TAS-102
2. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
3. Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
4. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
5. Global Pharmaceutical Industry Trends: Procurement Budgets Stay the Same, Marketing Budgets to Experience Slight Decrease
6. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2012 Financial Results Conference Call on Tuesday, March 19, 2013
7. Savara Pharmaceuticals Announces Formation of Clinical Advisory Board
8. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
9. UBM Launches PharmaEvolution.com, an Online Peer-to-Peer Network for Pharmaceutical Industry Professionals
10. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
11. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, March 4
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014 Echo Therapeutics, Inc. (NASDAQ: ... on skin permeation, continuous glucose monitoring and associated ... has been appointed Chief Executive Officer effective ... 20 years of experience in the medical device, ... served as Vice President, Business Development, Otsuka Pharmaceuticals as ...
(Date:12/24/2014)... -- ResMed (NYSE: RMD ) today announced its ... device manufacturer BMC Medical Co., Ltd. The ... below infringe ResMed,s patents, and entered an order prohibiting BMC ... the United States : , iVolve nasal ... nasal pillows mask , iVolve full face mask ...
(Date:12/24/2014)... , Dec. 23, 2014   Synageva BioPharma ... biopharmaceutical company developing therapeutic products for rare disorders, ... (EMA) of the Marketing Authorization Application (MAA) for ... granted the company,s request for accelerated assessment, which ... review time.   The MAA, and ...
Breaking Medicine Technology:Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3
... Covance Inc. (NYSE: CVD ) said ... repurchase of up to $250 million of its outstanding ... approximately 800,000 shares remaining under the repurchase authorization announced ... the Company,s common stock. Any purchases under this buyback ...
... announces that a new market research report ... Diagnostic Imaging Equipment - Emerging Markets ... – 2015". http://www.reportlinker.com/p0304719/Diagnostic-Imaging-Equipment---Emerging-Markets-BRIC--Brazil- ... for diagnostic imaging equipment in Brazil, Russia, ...
Cached Medicine Technology:Covance Board Authorizes $250 Million Stock Buyback 2Reportlinker Adds Diagnostic Imaging Equipment - Emerging Markets (BRIC- Brazil, Russia, India, and China) 2010 - 2015". 2Reportlinker Adds Diagnostic Imaging Equipment - Emerging Markets (BRIC- Brazil, Russia, India, and China) 2010 - 2015". 3Reportlinker Adds Diagnostic Imaging Equipment - Emerging Markets (BRIC- Brazil, Russia, India, and China) 2010 - 2015". 4Reportlinker Adds Diagnostic Imaging Equipment - Emerging Markets (BRIC- Brazil, Russia, India, and China) 2010 - 2015". 5Reportlinker Adds Diagnostic Imaging Equipment - Emerging Markets (BRIC- Brazil, Russia, India, and China) 2010 - 2015". 6Reportlinker Adds Diagnostic Imaging Equipment - Emerging Markets (BRIC- Brazil, Russia, India, and China) 2010 - 2015". 7Reportlinker Adds Diagnostic Imaging Equipment - Emerging Markets (BRIC- Brazil, Russia, India, and China) 2010 - 2015". 8
(Date:12/26/2014)... (PRWEB) December 26, 2014 Pentec Health, ... in the state of Pennsylvania for 2014. The awards ... statewide programs of its kind in the country. The ... the Pennsylvania Department of Community and Economic Development, the ... Management and the Central Penn Business Journal. ...
(Date:12/25/2014)... The click strand woven bamboo ... durability. Today, the business announces a click strand ... Jan. 30, 2015. , Click strand woven bamboo ... is a well-known brand in the bamboo industry. ... a reliable bamboo flooring supplier. , “We are ...
(Date:12/25/2014)... Recently, iFitDress.com, the popular online supplier of wedding dresses ... selection of black one-shoulder cocktail dresses . In addition, ... available at discounted prices, up to 70% off. ... three weeks only. You know, we have thousands of frequent ... our new items can visit our website for more details. ...
(Date:12/25/2014)... California (PRWEB) December 25, 2014 Helen ... home in Woodland Hills, California after an 8 year ... away on Christmas Eve evening in her home in ... aggressive metastatic breast cancer. , As ... over forty years, she pioneered and championed many of ...
(Date:12/25/2014)... Dec. 25, 2014 (HealthDay News) -- Overeating is common during ... eat in moderation, an expert says. "Don,t arrive at ... calories if you know you,ll be attending a party, but ... Ashbey-Pejoves, lead dietitian at Northern Westchester Hospital in Mount Kisco, ... to eat healthy during the day and even to have ...
Breaking Medicine News(10 mins):Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4
... especially ethnic and racial minorities, could get transplants, study ... umbilical cord blood transplant from an unrelated or unmatched ... as cancer and sickle cell anemia, Duke University Medical ... blood may be easier to obtain than adult bone ...
... Feb. 13 Symmetry Medical Inc. (NYSE: SMA ... orthopedic device industry and other medical markets, announced today that ... L. Hite, Senior Vice President and Chief Financial Officer, are ... the University of Nevada, Las Vegas on Tuesday, ...
... product line, including VETORYL(R) Capsules, now availableGLEN ... the nation,s largest practice-to-home delivery provider of ... announced an affiliation with Dechra Veterinary Products. ... expand its reach to veterinarians and pet ...
... Inc., will announce 2008 fourth quarter financial results on ... has been scheduled at 11 a.m., EST, for the ... In this call, representatives of US Oncology,s management team ... found on the company,s Web site, www.usoncology.co ...
... developed and tested a synthetic atherosclerosis drug that can ... producing the side-effect of fatty liver disease (which leads ... encouraging results of this study in mice could lead ... even prevent atherosclerosis. , Targets of this drug, called ...
... Professionals Meet on Expanding their Combination Products Research and Partnerships ... ... Needham, MA (PRWEB) February 13, 2009 -- ... recently posted details for its next executive forum - Combination ...
Cached Medicine News:Health News:Even Mismatched Cord Blood Can Help Kids 2Health News:VetCentric Partners with Dechra Veterinary Products 2Health News:Combination Products Executive Forum to be Hosted by CHI's Pharmaceutical Strategy Series 2Health News:Combination Products Executive Forum to be Hosted by CHI's Pharmaceutical Strategy Series 3
Near point card/newspaper 8 to 48 point type 5 1/2" X 8"....
Rosenbaum card fits in the pocket (3.5 by 6.5") and shows point, Jaeger and distance equivalents from 20/800 to 20/20. Uses numbers, directional Es and XO patterns. For use at 14" (35 mm). Includes f...
Standard reading test. "Value, care for..."...
Standard reading test. "Clearing weather..."...
Medicine Products: